Gabor G Illei

Author PubWeight™ 55.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification and characterization of circulating human transitional B cells. Blood 2005 3.62
2 Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010 3.24
3 The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012 3.14
4 A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 2003 2.11
5 Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus. Transfusion 2003 2.05
6 Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 2009 2.03
7 Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006 1.87
8 Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008 1.86
9 Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009 1.83
10 Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013 1.79
11 Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest 2003 1.63
12 MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010 1.59
13 miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol 2013 1.57
14 Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A 2012 1.38
15 Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009 1.38
16 MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum 2011 1.31
17 Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity 2009 1.31
18 Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 2012 1.30
19 Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum 2004 1.25
20 Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells. Blood 2004 1.23
21 Cytokines in Sjogren's syndrome: potential therapeutic targets. Ann Rheum Dis 2010 1.15
22 Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol 2009 1.15
23 Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Ann Rheum Dis 2012 1.10
24 Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med 2010 1.09
25 Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum 2006 1.06
26 Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta 2005 0.99
27 Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. Handb Exp Pharmacol 2009 0.96
28 MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010 0.94
29 Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of saliva. Hum Gene Ther 2006 0.87
30 A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus. Arthritis Rheum 2004 0.83
31 Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis. J Rheumatol 2002 0.82
32 Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One 2011 0.82
33 Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus. Endocr Metab Immune Disord Drug Targets 2009 0.81
34 Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice. Arthritis Rheum 2013 0.80
35 Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006 0.78
36 Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis. Clin Immunol 2003 0.78
37 Adrenomedullary response to glucagon in patients with primary Sjögren's syndrome. Cell Mol Neurobiol 2012 0.78
38 Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome. Arthritis Rheumatol 2015 0.77
39 The role of immune ablation and stem cell transplantation in severe SLE. Best Pract Res Clin Rheumatol 2005 0.77
40 The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland. Rheumatology (Oxford) 2012 0.77
41 Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty? Arthritis Rheum 2006 0.76
42 Can quantified salivary gland scintigraphy results aid diagnosis of patients with sicca symptoms? Nat Clin Pract Rheumatol 2008 0.75